NDC codes

FDA NDC Directory
Product NDC (as listed)63629-8259Labeler and product segments. Claims need a package NDC.
Product NDC at billing width63629-8259Add the package segment from the table below.
Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC11-digit (billing)PackageCopy
63629-8259-16362982590130 TABLET in 1 BOTTLE (63629-8259-1)Marketed from Feb 9, 2022
63629-8259-26362982590290 TABLET in 1 BOTTLE (63629-8259-2)Marketed from Feb 9, 2022

How the 11-digit form is made: The package segment has 1 digit, so one leading zero is added to it (5-4-1 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary)
Irbesartan
Generic name (nonproprietary)
irbesartan
Active ingredients
Irbesartan — 75 mg/1
Dosage form
Tablet
Route
Oral
Product type
Prescription drug
Marketing category
ANDA — Abbreviated New Drug Application (generic)Application ANDA 202254
Marketing start
Listing expires
Other FDA classes
Angiotensin 2 Receptor Antagonists (Mechanism)
Identifiers
Product ID 63629-8259_74e1f56c-cdb4-4a47-841a-c4b7f58ad986SPL ID 74e1f56c-cdb4-4a47-841a-c4b7f58ad986SPL set ID ed789dc1-0b39-4efc-990d-7b6b43a8b3baRxCUI 200094UNII J0E2756Z7N

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N463629825901 followed by a unit qualifier and the quantity

Package 63629-8259-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective . This label includes a boxed warning.

Indications (excerpt from the label)

Irbesartan is an angiotensin II receptor blocker (ARB) indicated for: • Treatment of hypertension, to lower blood pressure. Lowering blood pressure reduces the risk of fatal and nonfatal cardiovascular events, primarily strokes and myocardial infarctions. ( 1.1 ) • Treatment of diabetic nephropathy in hypertensive patients with type 2 diabetes, an elevated serum creatinine, and proteinuria. ( 1.2 ) 1.1 Hypertension Irbesartan tablets are indicated for the treatment of hypertension, to lower blood pressure. Lowering blood pressure lowers the risk of fatal and non-fatal cardiovascular (CV) events, primarily strokes and myocardial infarction. These benefits have been seen in controlled trials o…

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

Other NDCs under ANDA 202254

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 202254
ProductStrengthForm · routeLabelerProduct NDC
IrbesartanIrbesartan 300 mg/1TabletOralNorthStar RxLLC72603-672
IrbesartanIrbesartan 150 mg/1TabletOralBryant Ranch Prepack71335-1263
IrbesartanIrbesartan 300 mg/1TabletOralMacleods Pharmaceuticals Limited33342-049
IrbesartanIrbesartan 75 mg/1TabletOralMacleods Pharmaceuticals Limited33342-047
IrbesartanIrbesartan 150 mg/1TabletOralMacleods Pharmaceuticals Limited33342-048
IrbesartanIrbesartan 75 mg/1TabletOralProficient Rx LP71205-379
IrbesartanIrbesartan 150 mg/1TabletOralProficient Rx LP63187-737
IrbesartanIrbesartan 300 mg/1TabletOralBryant Ranch Prepack63629-5241
IrbesartanIrbesartan 150 mg/1TabletOralNorthStar RxLLC72603-671
IrbesartanIrbesartan 75 mg/1TabletOralNorthStar RxLLC72603-670

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free Med-Code account to keep looking up NDCs, J-codes and drugs.

Create a free accountLog in